EKF Diagnostics Investor Announcements

EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

Share purchase by Paul Foulger, outgoing Finance Director.

10th Dec 2015

EKF announces its Chief Technology Officer has resigned from the Board with immediate effect.

2nd Dec 2015

EKF announces that its Finance Director has resigned.

30th Nov 2015

EKF announces that two Non-Executive Directors have resigned.

26th Nov 2015

Trading update for the 12 months to 31 December 2015.

20th Nov 2015

EKF announces with regret that Kevin Wilson, Non-Executive Director, passed away peacefully today.

Closure of manufacturing site in Sanford, Florida.

EKF Diagnostics announces that Ron Zwanziger has been appointed as Non-Executive Chairman with immediate effect. 

EKF Diagnostics announces that Ron Zwanziger has been appointed as Non-Executive Chairman with immediate effect.

EKF Diagnostics, the global in vitro diagnostics company, announces that it will launch the Altair™ 240 clinical chemistry analyzer to the European market at Medica 2015, Düsseldorf, 16-19th November.